HI HCR194

Department of Law Enforcement is requested to conduct a study determining whether xylazine testing strips should be excluded from Hawaii's drug paraphernalia definition.

Xylazine is a non-opioid sedative approved only for veterinary use that is increasingly found mixed with fentanyl in the illicit drug supply, increasing overdose fatality risk.

Naloxone does not reverse xylazine effects and no FDA-approved reversal drug exists for xylazine in humans.

Multiple states have altered drug paraphernalia laws to legalize fentanyl and drug-checking test strips to combat overdose deaths.

Department of Law Enforcement must submit study findings, recommendations, and any proposed legislation to the Legislature no later than twenty days before the 2025 regular session convenes.